Publications
Unlipidated Anti-obesity Peptides Achieve Body Weight Reductions Similar to Those of Lipidated Counterparts - ObesityWeek, 2026A Platform for Ultralong-acting Anti-obesity Peptide Therapeutics Independent of Lipidation - ObesityWeek, 2026Ultralong-Acting Amylin Agonist Elicits Sustained 12-Week Weight Loss in DIO Rats After Single Dose - ObesityWeek, 2026When Can Weekly Anti-Obesity Peptides Be Used For Monthly Administration? - Diabetes Obes Metab, 2024The Limitation of Lipidation: Conversion of Semaglutide From Once-Weekly to Once-Monthly Dosing. - PNAS, 2024A once-monthly GLP-1 receptor agonist for treatment of diabetic cats. - Domestic Animal Endocrinology, 2020A Hydrogel-Microsphere Drug Delivery System That Supports Once-Monthly Administration of a GLP-1 Receptor Agonist. - ACS Chemical Biology, 2017Hydrogel Drug Delivery System Self-Cleaving Covalent Linkers for Once-a-Week Administration of Exenatide. - Bioconjugate Chemistry, 2016